Weekly Insulin: Convenience or Concern? What the Latest Trials Reveal

This episode of Rethinking Diabetes breaks down the newest evidence on once-weekly basal insulin, including data from five major trials and the surprising safety concerns that emerged. We explore real-world implications, from hypoglycemia risk to CGM-guided titration, and what it all means for patient selection, adherence, and the future of diabetes care.